Evidence map›Paper›PMID 36889863›Full record

ArticleThe Lancet. Planetary health2023

Food processing and cancer risk in Europe: results from the prospective EPIC cohort study.

Nathalie Kliemann, Fernanda Rauber, Renata Bertazzi Levy, Vivian Viallon, Eszter P Vamos, Reynalda Cordova, Heinz Freisling, Corinne Casagrande, Genevieve Nicolas, Dagfinn Aune and 23 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in The Lancet. Planetary health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 62 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 3 pooled it
29.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 3 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ultra-processed Foods and Gastrointestinal Cancer: Epidemiologic Evidence, Mechanistic Pathways, and Clinical Implications.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors at 18 institutions in 10 countries.

Nathalie KliemannInternational Agency for Research on Cancer, World Heath Organization, Lyon, France.
Fernanda RauberPreventive Medicine Department of the Medical School, University of São Paulo, São Paulo, Brazil.
Renata Bertazzi LevyPreventive Medicine Department of the Medical School, University of São Paulo, São Paulo, Brazil.
Vivian ViallonInternational Agency for Research on Cancer, World Heath Organization, Lyon, France.
Eszter P VamosPublic Health Policy Evaluation Unit, School of Public Health, Imperial College London, St Mary's Campus, London, UK.
Reynalda CordovaInternational Agency for Research on Cancer, World Heath Organization, Lyon, France.
Heinz FreislingInternational Agency for Research on Cancer, World Heath Organization, Lyon, France.
Corinne CasagrandeInternational Agency for Research on Cancer, World Heath Organization, Lyon, France.
Genevieve NicolasInternational Agency for Research on Cancer, World Heath Organization, Lyon, France.
Dagfinn AuneDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, London, UK; Department of Nutrition, Oslo New University College, Oslo, Norway; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Konstantinos K TsilidisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, London, UK; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Alicia HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, London, UK.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
Franziska JannaschDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; NutriAct-Competence Cluster Nutrition Research Berlin-Potsdam, Nuthetal, Germany.
Bernard SrourDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Miguel Rodriguez-BarrancoEscuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria, Granada, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Giovanna TagliabueCancer Registry Unit Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Antonio AgudoUnit of Nutrition and Cancer, Catalan Institute of Oncology (ICO), Nutrition and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Salvatore PanicoDipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Eva ArdanazCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Navarra Public Health Institute, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
María-Dolores ChirlaqueCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
Paolo VineisMRC Centre for Environment and Health, School of Public Health, Imperial College London, St Mary's Campus, London, UK.
Rosario TuminoCancer Registry and Histopathology Department, Provincial Health Authority (ASP) Ragusa, Italy.
Aurora Perez-CornagoCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Julie Louise Munk AndersenDanish Cancer Society Research Center, Unit of Diet, Genes and Environment, Copenhagen, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, Unit of Diet, Genes and Environment, Copenhagen, Denmark.
Guri SkeieDepartment of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.
Elisabete WeiderpassInternational Agency for Research on Cancer, World Heath Organization, Lyon, France.
Carlos Augusto MonteiroDepartment of Nutrition of the Faculty of Public Health, University of São Paulo, São Paulo, Brazil.
Marc J GunterInternational Agency for Research on Cancer, World Heath Organization, Lyon, France.
Christopher MillettPublic Health Policy Evaluation Unit, School of Public Health, Imperial College London, St Mary's Campus, London, UK; NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Centre (CHRC), NOVA University Lisbon, Lisbon, Portugal.
Inge HuybrechtsInternational Agency for Research on Cancer, World Heath Organization, Lyon, France. Electronic address: huybrechtsI@iarc.fr.
Centre international de recherche sur le cancer · FRImperial College London · GBUniversidade de São Paulo · BRCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDanish Cancer Society · DKFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Cancer Research Center · DEGerman Institute of Human Nutrition · DEHeidelberg University · DEInstitut Català d'Oncologia · ESInstituto Murciano de Investigación Biosanitaria · ESOsloMet – Oslo Metropolitan University · NOUiT The Arctic University of Norway · NOUniversidade Nova de Lisboa · PTUniversity of Ioannina · GRUniversity of Oxford · GBUniversity of Potsdam · DE

Funding

Cancer Research UK 14136Cancer Research UK 29017Cancer Research UK 29678Cancer Research UK C33493/A29678Cancer Research UK C8221/A29017Medical Research Council 1000143Medical Research Council MR/M012190/1Medical Research Council MR/S019669/1World Health Organization 001
6 · The paper itself

Abstract

backgroundFood processing has been hypothesised to play a role in cancer development; however, data from large-scale epidemiological studies are scarce. This study investigated the association between dietary intake according to amount of food processing and risk of cancer at 25 anatomical sites using data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

methodsThis study used data from the prospective EPIC cohort study, which recruited participants between March 18, 1991, and July 2, 2001, from 23 centres in ten European countries. Participant eligibility within each cohort was based on geographical or administrative boundaries. Participants were excluded if they had a cancer diagnosis before recruitment, had missing information for the NOVA food processing classification, or were within the top and bottom 1% for ratio of energy intake to energy requirement. Validated dietary questionnaires were used to obtain information on food and drink consumption. Participants with cancer were identified using cancer registries or during follow-up from a combination of sources, including cancer and pathology centres, health insurance records, and active follow-up of participants. We performed a substitution analysis to assess the effect of replacing 10% of processed foods and ultra-processed foods with 10% of minimally processed foods on cancer risk at 25 anatomical sites using Cox proportional hazard models.

findings521 324 participants were recruited into EPIC, and 450 111 were included in this analysis (318 686 [70·8%] participants were female individuals and 131 425 [29·2%] were male individuals). In a multivariate model adjusted for sex, smoking, education, physical activity, height, and diabetes, a substitution of 10% of processed foods with an equal amount of minimally processed foods was associated with reduced risk of overall cancer (hazard ratio 0·96, 95% CI 0·95-0·97), head and neck cancers (0·80, 0·75-0·85), oesophageal squamous cell carcinoma (0·57, 0·51-0·64), colon cancer (0·88, 0·85-0·92), rectal cancer (0·90, 0·85-0·94), hepatocellular carcinoma (0·77, 0·68-0·87), and postmenopausal breast cancer (0·93, 0·90-0·97). The substitution of 10% of ultra-processed foods with 10% of minimally processed foods was associated with a reduced risk of head and neck cancers (0·80, 0·74-0·88), colon cancer (0·93, 0·89-0·97), and hepatocellular carcinoma (0·73, 0·62-0·86). Most of these associations remained significant when models were additionally adjusted for BMI, alcohol and dietary intake, and quality.

interpretationThis study suggests that the replacement of processed and ultra-processed foods and drinks with an equal amount of minimally processed foods might reduce the risk of various cancer types.

fundingCancer Research UK, l'Institut National du Cancer, and World Cancer Research Fund International.

Indexed as

Carcinoma, HepatocellularColonic NeoplasmsLiver NeoplasmsCohort StudiesEuropeFemaleFood HandlingHumansMaleProspective StudiesRisk Factors

Identifiers

PMID36889863
PMCPMC10009757
OpenAlexW4323308389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.